malondialdehyde has been researched along with cannabidiol hydroxyquinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beeri, R; Kogan, NM; Marincheva, G; Mechoulam, R; Peters, M; Schlesinger, M | 1 |
1 other study(ies) available for malondialdehyde and cannabidiol hydroxyquinone
| Article | Year |
|---|---|
A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study.
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Body Weight; Cannabidiol; Cell Line, Tumor; Doxorubicin; Echocardiography; Heart; HT29 Cells; Humans; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred NOD; Mice, Inbred Strains; Mice, Nude; Mice, SCID; Molecular Structure; Myocardium; Neoplasms; Protein Carbonylation; Troponin T; Xenograft Model Antitumor Assays | 2007 |